The inhibitory effects of five alkaloids on the substrate transport mediated through human organic anion and cation transporters

References

• Badagnani I, Castro RA, Taylor TR, et al. (2006). Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. J Pharmacol Exp Therap 318:521–9
   PubMed Web of Science ®Google Scholar
• Bailey DG. (2010). Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol 70:645–55
   PubMed Web of Science ®Google Scholar
• Bhuiya S, Pradhan AB, Haque L, Das S. (2016). Molecular aspects of the interaction of iminium and alkanolamine forms of the anticancer alkaloid chelerythrine with plasma protein bovine serum albumin. J Phys Chem B 120:5–17
   PubMed Web of Science ®Google Scholar
• Burckhardt G. (2012). Drug transport by organic anion transporters (OATs). Pharmacol Ther 136:106–30
   PubMed Web of Science ®Google Scholar
• Chan T, Zhu L, Madigan MC, et al. (2015). Human organic anion transporting polypeptide 1A2 (OATP1A2) mediates cellular uptake of all-trans-retinol in human retinal pigmented epithelial cells. Br J Pharmacol 172:2343–53
   PubMed Web of Science ®Google Scholar
• Chmura SJ, Dolan ME, Cha A, et al. (2000). In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo. Clin Cancer Res 6:737–42
   PubMed Web of Science ®Google Scholar
• Cvetkovic M, Leake B, Fromm MF, et al. (1999). OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 27:866–71
   PubMed Web of Science ®Google Scholar
• DeGorter MK, Xia CQ, Yang JJ, Kim RB. (2012). Drug transporters in drug efficacy and toxicity. Annu Rev Pharmacol Toxicol 52:249–73
   PubMed Web of Science ®Google Scholar
• Dolton MJ, Roufogalis BD, McLachlan AJ. (2012). Fruit juices as perpetrators of drug interactions: the role of organic anion-transporting polypeptides. Clin Pharmacol Therap 92:622–30
   PubMed Web of Science ®Google Scholar
• Dostal J, Taborska E, Slavík J. (1995). Structure of chelerythrine base. J Nat Prod 58:723–9
   Web of Science ®Google Scholar
• Evans AM. (2000). Influence of dietary components on the gastrointestinal metabolism and transport of drugs. Ther Drug Monit 22:131–6
   PubMed Web of Science ®Google Scholar
• Fan R, Liu R, Ma R, et al. (2013). Determination of oxymatrine and its active metabolite matrine in human plasma after administration of oxymatrine oral solution by high-performance liquid chromatography coupled with mass spectrometry. Fitoterapia 89:271–7
   PubMed Web of Science ®Google Scholar
• Gai Z, Visentin M, Hiller C, et al. (2016). Organic cation transporter 2 overexpression may confer an increased risk of gentamicin-induced nephrotoxicity. Antimicrob Agents Chemother 60:5573–80
   PubMed Web of Science ®Google Scholar
• Gao B, Vavricka SR, Meier PJ, Stieger B. (2015). Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS. Pflugers Archiv 467:1481–93
   PubMed Web of Science ®Google Scholar
• Glaeser H, Bailey DG, Dresser GK, et al. (2007). Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Therap 81:362–70
   PubMed Web of Science ®Google Scholar
• Herbert JM, Augereau JM, Gleye J, Maffrand JP. (1990). Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172:993–9
   PubMed Web of Science ®Google Scholar
• Imamura Y, Tsuruya Y, Damme K, et al. (2014). 6beta-Hydroxycortisol is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3/SLC22A8, in healthy subjects. Drug Metab Dispos 42:685–94
   PubMed Web of Science ®Google Scholar
• Jahne EA, Eigenmann DE, Sampath C, et al. (2016). Pharmacokinetics and in vitro blood-brain barrier screening of the plant-derived alkaloid tryptanthrin. Planta Med 82:1021–9
   PubMed Web of Science ®Google Scholar
• Jahng Y. (2013). Progress in the studies on tryptanthrin, an alkaloid of history. Arch Pharmacol Res 36:517–35
   PubMed Web of Science ®Google Scholar
• Jao CW, Lin WC, Wu YT, Wu PL. (2008). Isolation, structure elucidation, and synthesis of cytotoxic tryptanthrin analogues from Phaius mishmensis. J Nat Prod 71:1275–9
   PubMed Web of Science ®Google Scholar
• Johnston RA, Rawling T, Chan T, et al. (2014). Selective inhibition of human solute carrier transporters by multikinase inhibitors. Drug Metab Dispos 42:1851–7
   PubMed Web of Science ®Google Scholar
• Kalliokoski A, Niemi M. (2009). Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 158:693–705
   PubMed Web of Science ®Google Scholar
• Kemeny-Beke A, Aradi J, Damjanovich J, et al. (2006). Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine. Cancer Lett 237:67–75
   PubMed Web of Science ®Google Scholar
• Kende AS, Bentley TJ, Mader RA, Ridge D. (1974). A simple total synthesis of (plus or minus)-dendrobine. J Am Chem Soc 96:4332–4
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Ohshiro N, Shibusawa A, et al. (2002). Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. Mol Pharmacol 62:7–14
   PubMed Web of Science ®Google Scholar
• Konig J, Muller F, Fromm MF. (2013). Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacol Rev 65:944–66
   PubMed Web of Science ®Google Scholar
• Konig J, Seithel A, Gradhand U, Fromm MF. (2006). Pharmacogenomics of human OATP transporters. Naunyn-Schmiedeberg’s Arch Pharmacol 372:432–43
   Google Scholar
• Kreis LM, Carreira EM. (2012). Total synthesis of (−)-dendrobine. Angew Chem 51:3436–9
   Google Scholar
• Lee W, Glaeser H, Smith LH, et al. (2005). Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. J Biol Chem 280:9610–17
   PubMed Web of Science ®Google Scholar
• Li W, Xing W, Niu X, et al. (2013). The pharmacokinetics of chelerythrine solution and chelerythrine liposomes after oral administration to rats. Planta Med 79:654–60
   PubMed Web of Science ®Google Scholar
• Li Z, Cheung FS, Zheng J, et al. (2014a). Interaction of the bioactive flavonol, icariin, with the essential human solute carrier transporters. J Biochem Mol Toxicol 28:91–7
   PubMed Web of Science ®Google Scholar
• Li Z, Wang K, Zheng J, et al. (2014b). Interactions of the active components of Punica granatum (pomegranate) with the essential renal and hepatic human Solute Carrier transporters. Pharm Biol 52:1510–17
   PubMed Web of Science ®Google Scholar
• Liu HC, Goldenberg A, Chen Y, et al. (2016). Molecular properties of drugs interacting with SLC22 transporters OAT1, OAT3, OCT1, and OCT2: a machine-learning approach. J Pharmacol Exp Therap 359:215–29
   PubMed Web of Science ®Google Scholar
• Malikova J, Zdarilova A, Hlobilkova A, Ulrichova J. (2006). The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine. Cell Biol Toxicol 22:439–53
   PubMed Web of Science ®Google Scholar
• Moon SY, Lee JH, Choi HY, et al. (2014). Tryptanthrin protects hepatocytes against oxidative stress via activation of the extracellular signal-regulated kinase/NF-E2-related factor 2 pathway. Biol Pharm Bull 37:1633–40
   PubMed Web of Science ®Google Scholar
• Muller F, Pontones CA, Renner B, et al. (2015). N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction. Eur J Clin Pharmacol 71:85–94
   PubMed Web of Science ®Google Scholar
• Nies AT, Koepsell H, Damme K, Schwab M. (2011). Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb Exp Pharmacol 201:105–67
   PubMedGoogle Scholar
• Padwa A, Dimitroff M, Liu B. (2000). Formal synthesis of (+/−)-dendrobine: use of the amidofuran cycloaddition/rearrangement sequence. Org Lett 2:3233–5
   PubMed Web of Science ®Google Scholar
• Pan X, Wang L, Grundemann D, Sweet DH. (2014). Inhibition of human organic cation transporters by the alkaloids matrine and oxymatrine. Fitoterapia 92:206–10
   PubMed Web of Science ®Google Scholar
• Parlakpinar H, Tasdemir S, Polat A, et al. (2006). Protective effect of chelerythrine on gentamicin-induced nephrotoxicity. Cell Biochem Funct 24:41–8
   PubMed Web of Science ®Google Scholar
• Roth M, Obaidat A, Hagenbuch B. (2012). OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol 165:1260–87
   PubMed Web of Science ®Google Scholar
• Sprowl JA, Sparreboom A. (2014). Uptake carriers and oncology drug safety. Drug Metab Dispos 42:611–22
   PubMed Web of Science ®Google Scholar
• Sun M, Cao H, Sun L, et al. (2012). Antitumor activities of kushen: literature review. Evid Based Complement Alternat Med 2012:373219
   PubMed Web of Science ®Google Scholar
• Tripathi A, Wadia N, Bindal D, Jana T. (2012). Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis. Indian J Biochem Biophys 49:435–41
   PubMed Web of Science ®Google Scholar
• Wang S, Wu H, Geng P, et al. (2016). Pharmacokinetic study of dendrobine in rat plasma by ultra-performance liquid chromatography tandem mass spectrometry. Biomed Chromatogr 30:1145–9
   PubMed Web of Science ®Google Scholar
• Wu C, Sun X, Feng C, et al. (2016). Proton-coupled organic cation antiporter contributes to the hepatic uptake of matrine. J Pharm Sci 105:1301–6
   PubMed Web of Science ®Google Scholar
• Xu C, Zhu L, Chan T, et al. (2016). Chloroquine and hydroxychloroquine are novel inhibitors of human organic anion transporting polypeptide 1A2. J Pharm Sci 105:884–90
   PubMed Web of Science ®Google Scholar
• Xu F, Li Z, Zheng J, et al. (2013). The inhibitory effects of the bioactive components isolated from Scutellaria baicalensis on the cellular uptake mediated by the essential solute carrier transporters. J Pharm Sci 102:4205–11
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu W, Zhang R, et al. (2008). Pharmacokinetic study of matrine, oxymatrine and oxysophocarpine in rat plasma after oral administration of Sophora flavescens Ait. extract by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal. 47:892–8
   PubMed Web of Science ®Google Scholar
• Zhang N, Hua Y, Wang C, et al. (2014). Distribution study of tryptanthrin in rat tissues by HPLC and its relationship with meridian tropism of indigo naturalis in traditional Chinese medicine. Biomed Chromatogr 28:1701–6
   PubMed Web of Science ®Google Scholar
• Zheng H, Chen G, Shi L, et al. (2009). Determination of oxymatrine and its metabolite matrine in rat blood and dermal microdialysates by high throughput liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal 49:427–33
   PubMed Web of Science ®Google Scholar
• Zheng J, Chan T, Zhu L, et al. (2016). The inhibitory effects of camptothecin (CPT) and its derivatives on the substrate uptakes mediated by human solute carrier transporters (SLCs). Xenobiotica 46:831–40
   PubMed Web of Science ®Google Scholar
• Zhou F, Lee AC, Krafczyk K, et al. (2011). Protein kinase C regulates the internalization and function of the human organic anion transporting polypeptide 1A2. Br J Pharmacol 162:1380–8
   PubMed Web of Science ®Google Scholar
• Zhou F, You G. (2007). Molecular insights into the structure-function relationship of organic anion transporters OATs. Pharm Res 24:28–36
   PubMed Web of Science ®Google Scholar
• Zhou F, Zheng J, Zhu L, et al. (2013). Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2. AAPS J 15:1099–108
   PubMed Web of Science ®Google Scholar
• Zhou F, Zhu L, Cui PH, et al. (2010). Functional characterization of nonsynonymous single nucleotide polymorphisms in the human organic anion transporter 4 (hOAT4). Br J Pharmacol 159:419–27
   PubMed Web of Science ®Google Scholar
• Zhou F, Zhu L, Wang K, Murray M. (2016). Recent advance in the pharmacogenomics of human solute carrier transporters (SLCs) in drug disposition. Adv Drug Deliv Rev. DOI:10.1016/j.addr.2016.06.004
   Web of Science ®Google Scholar